British Journal of Cancer, ISSN 0007-0920, 06/2015, Volume 113, Issue 1, pp. 150 - 158
Background: Peripheral blood-derived inflammation-based scores such as the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) have recently...
neutrophil lymphocyte ratio | platelet lymphocyte ratio | Breast cancer | Asia | survival | MORTALITY | PREDICTS | POPULATION | breast cancer | TUMORS | NEUTROPHIL/LYMPHOCYTE RATIO | ONCOLOGY | COLORECTAL-CANCER | INFLAMMATION | RECURRENCE | Blood Platelets - pathology | Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Breast Neoplasms - blood | Female | Breast Neoplasms - physiopathology | Neutrophils - pathology | Epidemiology
neutrophil lymphocyte ratio | platelet lymphocyte ratio | Breast cancer | Asia | survival | MORTALITY | PREDICTS | POPULATION | breast cancer | TUMORS | NEUTROPHIL/LYMPHOCYTE RATIO | ONCOLOGY | COLORECTAL-CANCER | INFLAMMATION | RECURRENCE | Blood Platelets - pathology | Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Breast Neoplasms - blood | Female | Breast Neoplasms - physiopathology | Neutrophils - pathology | Epidemiology
Journal Article
Medicine, ISSN 0025-7974, 06/2015, Volume 94, Issue 24, p. e993
The neutrophil/lymphocyte ratio (NLR), lymphocyte/monocyte ratio (LMR), and absolute lymphocyte count/absolute monocyte count prognostic score (ALC/AMC PS)...
SURVIVAL | MEDICINE, GENERAL & INTERNAL | IMPACT | POSITRON-EMISSION-TOMOGRAPHY | IPI | R-CHOP | INFLAMMATION | CLASSIFICATION | CANCER | CHEMOTHERAPY | Doxorubicin - therapeutic use | Neutrophils - cytology | Prognosis | Age Factors | Monocytes - cytology | Humans | Middle Aged | Male | Cyclophosphamide - therapeutic use | Young Adult | Aged, 80 and over | Adult | Female | Leukocyte Count | Lymphoma, Large B-Cell, Diffuse - drug therapy | Risk Factors | Lymphocytes - cytology | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Sex Factors | Survival Analysis | Taiwan | Vincristine - therapeutic use | Biomarkers | Lymphocyte Count | Aged | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Usage | B cells | Research | PET imaging | Gene expression | Blood cells
SURVIVAL | MEDICINE, GENERAL & INTERNAL | IMPACT | POSITRON-EMISSION-TOMOGRAPHY | IPI | R-CHOP | INFLAMMATION | CLASSIFICATION | CANCER | CHEMOTHERAPY | Doxorubicin - therapeutic use | Neutrophils - cytology | Prognosis | Age Factors | Monocytes - cytology | Humans | Middle Aged | Male | Cyclophosphamide - therapeutic use | Young Adult | Aged, 80 and over | Adult | Female | Leukocyte Count | Lymphoma, Large B-Cell, Diffuse - drug therapy | Risk Factors | Lymphocytes - cytology | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Sex Factors | Survival Analysis | Taiwan | Vincristine - therapeutic use | Biomarkers | Lymphocyte Count | Aged | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Usage | B cells | Research | PET imaging | Gene expression | Blood cells
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2013, Volume 88, Issue 1, pp. 218 - 230
Abstract There is increasing and consistent evidence that cancer-associated inflammation is a key determinant of outcome in patients with cancer. Various...
Hematology, Oncology and Palliative Medicine | Neutrophil lymphocyte ratio | Tumour-stage | Survival | Cancer | LIVER-TRANSPLANTATION | UNRESECTABLE HEPATOCELLULAR-CARCINOMA | CURATIVE RESECTION | ELEVATED PREOPERATIVE NEUTROPHIL | PREDICTS POOR SURVIVAL | PROGNOSTIC VALUE | HEPATIC RESECTION | NEUTROPHIL/LYMPHOCYTE RATIO | ONCOLOGY | PRETREATMENT NEUTROPHIL | RECURRENCE | HEMATOLOGY | Inflammation - pathology | Neoplasms - therapy | Prognosis | Neoplasms - immunology | Humans | Neoplasms - mortality | Inflammation - immunology | Leukocyte Count | Neoplasm Staging | Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - immunology | Neutrophil Infiltration - immunology | Medical colleges | Care and treatment | Cancer patients | Inflammation | Lymphocytes
Hematology, Oncology and Palliative Medicine | Neutrophil lymphocyte ratio | Tumour-stage | Survival | Cancer | LIVER-TRANSPLANTATION | UNRESECTABLE HEPATOCELLULAR-CARCINOMA | CURATIVE RESECTION | ELEVATED PREOPERATIVE NEUTROPHIL | PREDICTS POOR SURVIVAL | PROGNOSTIC VALUE | HEPATIC RESECTION | NEUTROPHIL/LYMPHOCYTE RATIO | ONCOLOGY | PRETREATMENT NEUTROPHIL | RECURRENCE | HEMATOLOGY | Inflammation - pathology | Neoplasms - therapy | Prognosis | Neoplasms - immunology | Humans | Neoplasms - mortality | Inflammation - immunology | Leukocyte Count | Neoplasm Staging | Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - immunology | Neutrophil Infiltration - immunology | Medical colleges | Care and treatment | Cancer patients | Inflammation | Lymphocytes
Journal Article
Annals of Surgery, ISSN 0003-4932, 08/2013, Volume 258, Issue 2, pp. 301 - 305
OBJECTIVE:To clarify the prognostic value of the preoperative blood neutrophil-to-lymphocyte ratio (NLR) in patients undergoing hepatectomy for hepatocellular...
liver resection | tumor-associated macrophage | prognosis | hepatocellular carcinoma | blood neutrophil-to-lymphocyte ratio | C-REACTIVE PROTEIN | ACTIVATED MONOCYTES | SURGERY | PORTAL-VEIN | LIVER-TRANSPLANTATION | RISK-FACTORS | CURATIVE RESECTION | HEPATIC RESECTION | PROMOTE EXPANSION | INFLAMMATION | TUMOR-ASSOCIATED MACROPHAGES | Lymphocytes - metabolism | Multivariate Analysis | Carcinoma, Hepatocellular - mortality | Humans | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Treatment Outcome | Biomarkers - blood | Liver Neoplasms - mortality | Hepatectomy | Liver Neoplasms - blood | Survival Analysis | Female | ROC Curve | Aged | Leukocyte Count | Retrospective Studies | Carcinoma, Hepatocellular - blood | Neutrophils - metabolism | Preoperative Period
liver resection | tumor-associated macrophage | prognosis | hepatocellular carcinoma | blood neutrophil-to-lymphocyte ratio | C-REACTIVE PROTEIN | ACTIVATED MONOCYTES | SURGERY | PORTAL-VEIN | LIVER-TRANSPLANTATION | RISK-FACTORS | CURATIVE RESECTION | HEPATIC RESECTION | PROMOTE EXPANSION | INFLAMMATION | TUMOR-ASSOCIATED MACROPHAGES | Lymphocytes - metabolism | Multivariate Analysis | Carcinoma, Hepatocellular - mortality | Humans | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Treatment Outcome | Biomarkers - blood | Liver Neoplasms - mortality | Hepatectomy | Liver Neoplasms - blood | Survival Analysis | Female | ROC Curve | Aged | Leukocyte Count | Retrospective Studies | Carcinoma, Hepatocellular - blood | Neutrophils - metabolism | Preoperative Period
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/2014, Volume 106, Issue 6, p. dju124
Background Inflammation may play an important role in cancer progression, and a high neutrophil-to-lymphocyte ratio (NLR) has been reported to be a poor...
C-REACTIVE PROTEIN | DISEASE-SPECIFIC SURVIVAL | HEPATOCELLULAR-CARCINOMA | COLORECTAL-CANCER PATIENTS | ONCOLOGY | ACTIVATED HUMAN-NEUTROPHILS | PRETREATMENT NEUTROPHIL | CELL CARCINOMA PATIENTS | PREDICTS POOR SURVIVAL | INFLAMMATORY RESPONSE | PREOPERATIVE NEUTROPHIL/LYMPHOCYTE RATIO | Predictive Value of Tests | Prognosis | Humans | Neoplasms - mortality | Survival Rate | Treatment Outcome | Disease-Free Survival | Lymphocytes - pathology | Sensitivity and Specificity | Lymphocyte Count | Neoplasms - pathology | Odds Ratio | Neutrophils - pathology | Physiological aspects | Development and progression | Research | Lymphocytes | Neutrophils | Tumors
C-REACTIVE PROTEIN | DISEASE-SPECIFIC SURVIVAL | HEPATOCELLULAR-CARCINOMA | COLORECTAL-CANCER PATIENTS | ONCOLOGY | ACTIVATED HUMAN-NEUTROPHILS | PRETREATMENT NEUTROPHIL | CELL CARCINOMA PATIENTS | PREDICTS POOR SURVIVAL | INFLAMMATORY RESPONSE | PREOPERATIVE NEUTROPHIL/LYMPHOCYTE RATIO | Predictive Value of Tests | Prognosis | Humans | Neoplasms - mortality | Survival Rate | Treatment Outcome | Disease-Free Survival | Lymphocytes - pathology | Sensitivity and Specificity | Lymphocyte Count | Neoplasms - pathology | Odds Ratio | Neutrophils - pathology | Physiological aspects | Development and progression | Research | Lymphocytes | Neutrophils | Tumors
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 05/2016, Volume 113, Issue 6, pp. 621 - 627
Background This study aimed to determine preoperative predictors of early (<1 year) mortality from disease recurrence after liver resection (LR) for huge (≥10...
platelet‐to‐lymphocyte ratio | huge | neutrophil‐to‐lymphocyte ratio | prognostic nutrition index | hepatocellular carcinoma | platelet-to-lymphocyte ratio | neutrophil-to-lymphocyte ratio | SURVIVAL | SURGERY | TUMOR RECURRENCE | SCORE | HEPATECTOMY | SIZE | HEPATIC RESECTION | MICROVASCULAR INVASION | ONCOLOGY | EXPERIENCE | SURGICAL RESECTION | Carcinoma, Hepatocellular - mortality | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Hepatectomy - mortality | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - etiology | Nutrition Assessment | Liver Neoplasms - blood | Adult | Female | Liver Neoplasms - pathology | Leukocyte Count | Nutritional Status | Retrospective Studies | Carcinoma, Hepatocellular - blood | Neoplasm Recurrence, Local - blood | Neutrophils - metabolism | Biomarkers - metabolism | Lymphocytes - metabolism | Hospital Mortality | Risk Factors | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Tumor Burden | Platelet Count | Blood Platelets - metabolism | Carcinoma, Hepatocellular - pathology | Survival Analysis | ROC Curve | Aged
platelet‐to‐lymphocyte ratio | huge | neutrophil‐to‐lymphocyte ratio | prognostic nutrition index | hepatocellular carcinoma | platelet-to-lymphocyte ratio | neutrophil-to-lymphocyte ratio | SURVIVAL | SURGERY | TUMOR RECURRENCE | SCORE | HEPATECTOMY | SIZE | HEPATIC RESECTION | MICROVASCULAR INVASION | ONCOLOGY | EXPERIENCE | SURGICAL RESECTION | Carcinoma, Hepatocellular - mortality | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Hepatectomy - mortality | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - etiology | Nutrition Assessment | Liver Neoplasms - blood | Adult | Female | Liver Neoplasms - pathology | Leukocyte Count | Nutritional Status | Retrospective Studies | Carcinoma, Hepatocellular - blood | Neoplasm Recurrence, Local - blood | Neutrophils - metabolism | Biomarkers - metabolism | Lymphocytes - metabolism | Hospital Mortality | Risk Factors | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Tumor Burden | Platelet Count | Blood Platelets - metabolism | Carcinoma, Hepatocellular - pathology | Survival Analysis | ROC Curve | Aged
Journal Article
Lung Cancer, ISSN 0169-5002, 09/2017, Volume 111, pp. 176 - 181
Immunotherapy with the programmed death receptor-1 (PD-1) antibody nivolumab has changed the field of metastatic non-small cell lung cancer (NSCLC) treatment....
Neutrophil-to-Lymphocyte ratio | Overall survival | Non small cell lung cancer | Platelet-to-Lymphocyte ratio | Immunotherapy | SURVIVAL | SOLID TUMORS | DOCETAXEL | CHEMOTHERAPY | TRIAL | METASTATIC MELANOMA | ONCOLOGY | RESPIRATORY SYSTEM | INFLAMMATION | EXPERIENCE | OUTCOMES | IPILIMUMAB | Lung Neoplasms - drug therapy | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Molecular Targeted Therapy | Neoplasm Metastasis | Aged, 80 and over | Female | Leukocyte Count | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Neutrophils | Carcinoma, Non-Small-Cell Lung - mortality | Platelet Count | Antineoplastic Agents, Immunological - therapeutic use | Survival Analysis | Biomarkers | Lymphocyte Count | Carcinoma, Non-Small-Cell Lung - blood | Aged | Lung Neoplasms - blood | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Care and treatment | Lymphocytes | Analysis | Lung cancer, Small cell | Development and progression | Lung cancer, Non-small cell
Neutrophil-to-Lymphocyte ratio | Overall survival | Non small cell lung cancer | Platelet-to-Lymphocyte ratio | Immunotherapy | SURVIVAL | SOLID TUMORS | DOCETAXEL | CHEMOTHERAPY | TRIAL | METASTATIC MELANOMA | ONCOLOGY | RESPIRATORY SYSTEM | INFLAMMATION | EXPERIENCE | OUTCOMES | IPILIMUMAB | Lung Neoplasms - drug therapy | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Molecular Targeted Therapy | Neoplasm Metastasis | Aged, 80 and over | Female | Leukocyte Count | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Neutrophils | Carcinoma, Non-Small-Cell Lung - mortality | Platelet Count | Antineoplastic Agents, Immunological - therapeutic use | Survival Analysis | Biomarkers | Lymphocyte Count | Carcinoma, Non-Small-Cell Lung - blood | Aged | Lung Neoplasms - blood | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Care and treatment | Lymphocytes | Analysis | Lung cancer, Small cell | Development and progression | Lung cancer, Non-small cell
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 2014, Volume 23, Issue 7, pp. 1204 - 1212
Background: Inflammation influences cancer development and progression. An elevated platelet to lymphocyte ratio (PLR), a marker of inflammation, has been...
SURVIVAL | CELLS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PREDICTOR | ONCOLOGY | MARKER | SCORES | SUPERIOR | NEUTROPHIL-LYMPHOCYTE | INFLAMMATORY RESPONSE | INTERLEUKIN-6 | CANCER | Lymphocyte Count | Neoplasms - mortality | Neoplasms - blood | Platelet Count | Prognosis | Humans
SURVIVAL | CELLS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PREDICTOR | ONCOLOGY | MARKER | SCORES | SUPERIOR | NEUTROPHIL-LYMPHOCYTE | INFLAMMATORY RESPONSE | INTERLEUKIN-6 | CANCER | Lymphocyte Count | Neoplasms - mortality | Neoplasms - blood | Platelet Count | Prognosis | Humans
Journal Article
Biomarkers, ISSN 1354-750X, 5/2012, Volume 17, Issue 3, pp. 216 - 222
The objective of this study was to clarify whether the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) are significant prognostic...
platelet-lymphocyte ratio | Colorectal carcinoma | neutrophil-lymphocyte ratio | Neutrophil-lymphocyte ratio | Platelet-lymphocyte ratio | SURVIVAL | TUMOR RECURRENCE | CYTOKINES | PROGNOSTIC-FACTORS | CURATIVE RESECTION | RISK | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | KINETICS | SYSTEMIC INFLAMMATORY RESPONSE | TOXICOLOGY | THROMBOCYTOSIS | ASSOCIATION | Colorectal Neoplasms - surgery | Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Female | Male | Colorectal Neoplasms - pathology | Neutrophils - pathology
platelet-lymphocyte ratio | Colorectal carcinoma | neutrophil-lymphocyte ratio | Neutrophil-lymphocyte ratio | Platelet-lymphocyte ratio | SURVIVAL | TUMOR RECURRENCE | CYTOKINES | PROGNOSTIC-FACTORS | CURATIVE RESECTION | RISK | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | KINETICS | SYSTEMIC INFLAMMATORY RESPONSE | TOXICOLOGY | THROMBOCYTOSIS | ASSOCIATION | Colorectal Neoplasms - surgery | Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Female | Male | Colorectal Neoplasms - pathology | Neutrophils - pathology
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2013, Volume 13, Issue 1, pp. 350 - 350
Background: Several inflammatory response materials could be used for prediction of prognosis of cancer patients. The neutrophil lymphocyte ratio (NLR), and...
Platelet | Neutrophil | Gastric neoplasm | Lymphocyte | LEUCOVORIN | STATISTICS | OXALIPLATIN | PREVALENCE | PREOPERATIVE NEUTROPHIL | 5-FLUOROURACIL | ONCOLOGY | COLORECTAL-CANCER | INFLAMMATION | GLUTATHIONE-S-TRANSFERASE | THYMIDYLATE-SYNTHASE | Prognosis | Humans | Middle Aged | Organoplatinum Compounds | Male | Leucovorin | Young Adult | Lymphocytes | Adult | Female | Leukocyte Count | Fluorouracil | Adenocarcinoma - blood | Adenocarcinoma - immunology | Blood Platelets | Kaplan-Meier Estimate | Neutrophils | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Stomach Neoplasms - immunology | Disease-Free Survival | Stomach Neoplasms - blood | Aged | Cancer patients | Chemotherapy | Patient outcomes | Dosage and administration | Drug therapy | Properties | Stomach cancer | Cancer | Usage | Care and treatment | Medical examination | Blood | Analysis | 5-Fluorouracil
Platelet | Neutrophil | Gastric neoplasm | Lymphocyte | LEUCOVORIN | STATISTICS | OXALIPLATIN | PREVALENCE | PREOPERATIVE NEUTROPHIL | 5-FLUOROURACIL | ONCOLOGY | COLORECTAL-CANCER | INFLAMMATION | GLUTATHIONE-S-TRANSFERASE | THYMIDYLATE-SYNTHASE | Prognosis | Humans | Middle Aged | Organoplatinum Compounds | Male | Leucovorin | Young Adult | Lymphocytes | Adult | Female | Leukocyte Count | Fluorouracil | Adenocarcinoma - blood | Adenocarcinoma - immunology | Blood Platelets | Kaplan-Meier Estimate | Neutrophils | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Stomach Neoplasms - immunology | Disease-Free Survival | Stomach Neoplasms - blood | Aged | Cancer patients | Chemotherapy | Patient outcomes | Dosage and administration | Drug therapy | Properties | Stomach cancer | Cancer | Usage | Care and treatment | Medical examination | Blood | Analysis | 5-Fluorouracil
Journal Article
Annals of Oncology, ISSN 0923-7534, 04/2016, Volume 27, Issue 4, pp. 732 - 738
Journal Article
British Journal of Cancer, ISSN 0007-0920, 08/2012, Volume 107, Issue 4, pp. 695 - 699
BACKGROUND: The neutrophil lymphocyte ratio (NLR) has prognostic value in patients with a variety of cancers. Many chemotherapeutic trial databases hold...
survival analysis | neutrophil | prognosis | oncology | lymphocyte | SITE | RESECTION | PROGNOSTIC SCORE | MARKERS | ELEVATED PREOPERATIVE NEUTROPHIL | NEUTROPHIL/LYMPHOCYTE RATIO | INFLAMMATION | RECURRENCE | Colorectal Neoplasms - mortality | Prognosis | Colorectal Neoplasms - blood | Humans | Middle Aged | Neutrophils - immunology | Neoplasms - mortality | Male | Neoplasms - blood | Lymphocyte Count | Female | Aged | Leukocyte Count | Blood | Molecular Diagnostics
survival analysis | neutrophil | prognosis | oncology | lymphocyte | SITE | RESECTION | PROGNOSTIC SCORE | MARKERS | ELEVATED PREOPERATIVE NEUTROPHIL | NEUTROPHIL/LYMPHOCYTE RATIO | INFLAMMATION | RECURRENCE | Colorectal Neoplasms - mortality | Prognosis | Colorectal Neoplasms - blood | Humans | Middle Aged | Neutrophils - immunology | Neoplasms - mortality | Male | Neoplasms - blood | Lymphocyte Count | Female | Aged | Leukocyte Count | Blood | Molecular Diagnostics
Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2014, Volume 134, Issue 10, pp. 2403 - 2413
The prognostic role of inflammation index like neutrophil‐to‐lymphocyte ratio (NLR) in colorectal cancer (CRC) remains controversial. We conduct a...
colorectal cancer | neutrophil‐to‐lymphocyte ratio | meta‐analysis | prognosis | meta-analysis | neutrophil-to-lymphocyte ratio | SURVIVAL | METAANALYSIS | STATISTICS | CURATIVE RESECTION | RISK | ELEVATED PREOPERATIVE NEUTROPHIL | CHEMOTHERAPY | COLON-CANCER | ONCOLOGY | POOR-PROGNOSIS | INFLAMMATORY RESPONSE | Disease-Free Survival | Colorectal Neoplasms - therapy | Lymphocytes - pathology | Prognosis | Humans | Lymphocyte Count | Colorectal Neoplasms - pathology | Neoplasm Staging | Colorectal Neoplasms - metabolism | Carcinoembryonic Antigen - metabolism | Neutrophils - pathology | Lymphocytes | Analysis | Colorectal cancer | Leucocytes | Systematic review | Meta-analysis
colorectal cancer | neutrophil‐to‐lymphocyte ratio | meta‐analysis | prognosis | meta-analysis | neutrophil-to-lymphocyte ratio | SURVIVAL | METAANALYSIS | STATISTICS | CURATIVE RESECTION | RISK | ELEVATED PREOPERATIVE NEUTROPHIL | CHEMOTHERAPY | COLON-CANCER | ONCOLOGY | POOR-PROGNOSIS | INFLAMMATORY RESPONSE | Disease-Free Survival | Colorectal Neoplasms - therapy | Lymphocytes - pathology | Prognosis | Humans | Lymphocyte Count | Colorectal Neoplasms - pathology | Neoplasm Staging | Colorectal Neoplasms - metabolism | Carcinoembryonic Antigen - metabolism | Neutrophils - pathology | Lymphocytes | Analysis | Colorectal cancer | Leucocytes | Systematic review | Meta-analysis
Journal Article